시장보고서
상품코드
1810951

세계의 건강검진 시장 보고서(2025년)

Medical Health Screening Global Market Report 2025

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계의 건강검진 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년까지 CAGR 6.5%로 확대되어 253억 6,000만 달러로 성장할 것으로 예상됩니다. 예측기간 성장은 맞춤형 의료 확대, 디지털 건강 플랫폼 투자 증가, 비감염성 질환(NCDs) 유병률 상승, 신흥 시장의 중간층 증가, 건강 의식 증가 등으로 인한 것으로 보입니다. 이 기간에 예상되는 주요 동향으로는 진단 해석에서 인공지능 사용, 웨어러블 건강 모니터링 장비, 텔레헬스 통합 검진 툴, 휴대용 및 휴대용 검진 장비, 검진 프로토콜의 AI 통합, 건강 데이터 보안을 위한 블록체인 기술 등이 있습니다.

만성 질환의 유병률 증가는 향후 수년간 건강검진 시장의 성장을 가속할 것으로 예측됩니다. 만성 질환은 당뇨병, 심장병, 천식과 같은 장기적인 건강 상태이며 일반적으로 1년 이상 지속되어 지속적인 의료가 필요하거나 일상적인 활동을 제한합니다. 이러한 만성 질환 증가는 장기간의 운동 부족이 전신의 건강을 약화시키고 장기적인 질병에 대한 위험성을 높이는 앉기 쉬운 라이프 스타일에 의한 것이 큽니다. 건강검진은 위험 요인과 증상의 조기 발견을 가능하게 하고 적시에 개입과 관리를 가능하게 함으로써 만성 질환 관리에 중요한 역할을 합니다. 이것은 합병증을 예방하고 삶의 질을 향상시키고 이러한 질병의 전반적인 영향을 줄일 수 있습니다. 예를 들어 벨기에에 본부를 둔 비영리 단체인 국제 당뇨병 연합은 2025년 4월 현재 세계에서 20-79세의 성인 5억 8,900만명이 당뇨병을 앓고 있다고 보고했고, 그 수는 2050년까지 8억 5,300만명으로 증가할 것으로 예측했습니다. 이와 같이 만성질환의 부담 증가가 의료건강 스크리닝 시장 확대에 박차를 가하고 있습니다.

건강검진 시장의 주요 기업은 조기 발견, 진단 정확성, 임상 워크플로우의 효율성을 향상시키기 위해 인공지능(AI)을 탑재한 방사선학 인포매틱스 및 암 스크리닝 기술 등 최첨단 솔루션의 도입에 주력하고 있습니다. AI를 활용한 방사선 정보학과 암 검진은 AI를 활용하여 의료 영상 데이터를 분석하여 암 및 기타 이상 징후를 보다 신속하고 정확하게 검출합니다. 예를 들어, 2025년 2월 미국을 거점으로 하는 의료 정보학 기업인 DeepHealth사는 클라우드 네이티브 플랫폼인 DeepHealth OS를 통해 AI를 활용한 방사선학 정보학 및 암 검진 툴의 새로운 시리즈를 발표했습니다. 이 제품군에는 종합적인 AI 기반 진단 작업 공간인 Diagnostic Suite와 폐, 전립선 및 뇌 건강을 선별하기 위한 고급 AI 애플리케이션이 포함되어 있습니다. 이러한 혁신은 진단 정확도를 높이고, 임상 프로세스를 간소화하고, 다양한 건강 관리 환경에 걸쳐 업무 효율성을 높이기 위해 고안되었습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

  • 세계 건강검진 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
  • 최종 이용 산업의 분석
  • 세계 건강검진 시장 : 성장률 분석
  • 세계 건강검진 시장 실적 : 규모와 성장, 2019-2024
  • 세계 건강검진 시장 예측 : 규모와 성장, 2024-2029, 2034F
  • 세계 건강검진 시장 : 총 시장 규모(TAM)

제6장 시장 세분화

  • 세계 건강검진 시장 : 검사 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
  • 정기 검사
  • 비정기 검사
  • 암 검진
  • 전문 검사
  • 기타 검사 유형
  • 세계 건강검진 시장 : 샘플 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
  • 소변
  • 타액
  • 기타 샘플 유형
  • 세계 건강검진 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
  • 병원 및 진료소의 진단 실험실
  • 직장
  • 연구기관
  • 기타 최종 사용자
  • 세계의 건강검진 시장 : 정기 검사 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
  • 혈압 모니터링
  • 혈당 검사
  • 지질 프로파일
  • 전혈구 수(CBC)
  • 소변 검사
  • 세계의 건강검진 시장 : 비정기 검사 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
  • 유전자 검사
  • 호르몬 검사
  • 알레르기 검사
  • 감염증 검사
  • 세계의 건강검진 시장 : 암 검사 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
  • 유방 조영
  • 팝 스메어 검사
  • 대장 내시경 검사
  • 전립선 특이 항원(PSA) 검사
  • 폐암 저선량 CT 스캔
  • 세계의 건강검진 시장 : 전문 검사 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
  • 심혈관 스크리닝
  • 신경학적 스크리닝
  • 폐기능검사
  • 골밀도 검사
  • 세계 건강검진 시장 : 기타 검사 유형별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
  • 건강검진
  • 이그제큐티브 건강검진
  • 출생 전 스크리닝
  • 직업 건강검진

제7장 지역별/국가별 분석

  • 세계 건강검진 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F
  • 세계 건강검진 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

  • 건강검진 시장 : 경쟁 구도
  • 건강검진 시장 : 기업 프로파일
    • Abbott Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Siemens Healthineers AG : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Labcorp Holdings Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Quest Diagnostics Incorporated : 개요, 제품 및 서비스, 전략 및 재무 분석
    • Eurofins Scientific SE : 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

  • QuidelOrtho Corporation
  • Teladoc Health Inc.
  • Exact Sciences Corporation
  • Unilabs AB
  • LifeLabs LP
  • ARUP Laboratories
  • BioReference Health LLC
  • Guardant Health Inc.
  • DDRC Agilus Diagnostics Limited
  • Clinical Reference Laboratory Inc.
  • Freenome Holdings Inc.
  • Genova Diagnostics Inc.
  • Cerba Healthcare SAS
  • DELFI Diagnostics Inc.
  • Truvian Sciences Inc.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

  • 건강검진 시장(2029년) : 새로운 기회를 제공하는 국가
  • 건강검진 시장(2029년) : 새로운 기회를 제공하는 부문
  • 건강검진 시장(2029년) : 성장 전략
    • 시장 동향에 기초한 전략
    • 경쟁 전략

제36장 부록

JHS 25.09.24

Medical health screening is the systematic process of performing various tests and examinations on seemingly healthy individuals to detect potential health issues or risk factors before symptoms develop. This early detection strategy allows healthcare providers to take timely action, lessen disease severity, and enhance overall health outcomes through preventive care.

The primary categories of tests in medical health screening include routine tests, non-routine tests, cancer screening tests, specialty tests, and others. Routine tests are standard medical examinations conducted regularly to monitor general health and identify potential problems early. These tests involve different sample types, such as blood, urine, saliva, and others, and serve a wide range of end users, including hospitals and clinics, diagnostic laboratories, workplaces, research institutions, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The medical health screening market research report is one of a series of new reports from The Business Research Company that provides medical health screening market statistics, including medical health screening industry global market size, regional shares, competitors with a medical health screening market share, detailed medical health screening market segments, market trends and opportunities, and any further data you may need to thrive in the medical health screening industry. This medical health screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical health screening market size has grown strongly in recent years. It will grow from $18.50 billion in 2024 to $19.74 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth during the historic period can be attributed to the rising incidence of chronic diseases, government-driven preventive health campaigns, an aging global population, expanded insurance coverage, and a higher frequency of routine check-ups.

The medical health screening market size is expected to see strong growth in the next few years. It will grow to $25.36 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to the expansion of personalized medicine, increased investment in digital health platforms, the rising prevalence of non-communicable diseases (NCDs), the growing middle class in emerging markets, and heightened health consciousness. Key trends expected during this period include the use of artificial intelligence in diagnostic interpretation, wearable health monitoring devices, telehealth-integrated screening tools, portable and handheld screening devices, AI integration in screening protocols, and blockchain technology for health data security.

The rising prevalence of chronic diseases is expected to drive the growth of the medical health screening market in the coming years. Chronic diseases are long-term health conditions-such as diabetes, heart disease, and asthma-that typically last a year or more and require ongoing medical care or limit daily activities. This increase in chronic diseases is largely due to sedentary lifestyles, where extended inactivity weakens overall health and raises susceptibility to long-term conditions. Medical health screening plays a crucial role in managing chronic diseases by enabling early detection of risk factors and symptoms, which allows for timely intervention and management. This can help prevent complications, improve quality of life, and lessen the overall impact of these diseases. For example, in April 2025, the International Diabetes Federation, a Belgium-based non-profit organization, reported that 589 million adults aged 20-79 are currently living with diabetes worldwide, a number projected to rise to 853 million by 2050. Thus, the growing burden of chronic diseases is fueling the expansion of the medical health screening market.

Key players in the medical health screening market are focusing on introducing cutting-edge solutions such as artificial intelligence (AI)-powered radiology informatics and cancer screening technologies to improve early detection, diagnostic accuracy, and clinical workflow efficiency. AI-powered radiology informatics and cancer screening involve using AI to analyze medical imaging data and detect signs of cancer or other abnormalities more quickly and accurately. For instance, in February 2025, DeepHealth, a US-based health informatics company, launched a new range of AI-driven radiology informatics and cancer screening tools through their cloud-native platform, DeepHealth OS. This suite includes the Diagnostic Suite, a comprehensive AI-based diagnostic workspace, along with advanced AI applications for screening lung, prostate, and brain health. These innovations are designed to boost diagnostic precision, streamline clinical processes, and enhance operational efficiency across various healthcare environments.

In January 2023, PAM Group, a UK-based provider of occupational health, rehabilitation, and absence management services, acquired MedProtect for an undisclosed sum. This acquisition is aimed at strengthening PAM Group's position in the occupational health and wellbeing sector by integrating MedProtect's specialized mobile health screening services. The combined entity is now able to offer more cost-effective health solutions to a wider client base while promoting continued growth and innovation within the industry. MedProtect, based in the UK, offers occupational health screening services, including mobile units for hearing tests, biological monitoring, and lung function evaluations.

Major players in the medical health screening market are Abbott Laboratories, Siemens Healthineers AG, Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific SE, QuidelOrtho Corporation, Teladoc Health Inc., Exact Sciences Corporation, Unilabs AB, LifeLabs LP, ARUP Laboratories, BioReference Health LLC, Guardant Health Inc., DDRC Agilus Diagnostics Limited, Clinical Reference Laboratory Inc., Freenome Holdings Inc., Genova Diagnostics Inc., Cerba Healthcare SAS, DELFI Diagnostics Inc., Truvian Sciences Inc., ACM Medical Laboratory Inc., LabPlus, and BlueHive Health.

North America was the largest region in the medical health screening market in 2024. The regions covered in medical health screening report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the medical health screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical health screening market includes revenues earned by entities by providing services such as blood pressure measurement, mental health assessment, infectious disease screening, immunization status review, and lifestyle risk assessments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Health Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical health screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical health screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical health screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Routine Tests; Non-Routine Tests; Cancer Screening Tests; Specialty Tests; Other Test Types
  • 2) By Sample Type: Blood; Urine; Saliva; Other Sample Types
  • 3) By End User: Hospitals Or Clinics Diagnostic Laboratories; Workplaces; Research Institutes; Other End Users
  • Subsegments:
  • 1) By Routine Tests: Blood Pressure Monitoring; Blood Glucose Testing; Lipid Profile; Complete Blood Count (CBC); Urinalysis
  • 2) By Non-Routine Tests: Genetic Testing; Hormonal Testing; Allergy Testing; Infectious Disease Testing
  • 3) By Cancer Screening Tests: Mammography; Pap Smear Test; Colonoscopy; Prostate-Specific Antigen (PSA) Test; Low-Dose CT Scan For Lung Cancer
  • 4) By Specialty Tests: Cardiovascular Screening; Neurological Screening; Pulmonary Function Tests; Bone Density Test
  • 5) By Other Test Types: Wellness Tests; Executive Health Checkups; Prenatal Screening; Occupational Health Screening
  • Companies Mentioned: Abbott Laboratories; Siemens Healthineers AG; Labcorp Holdings Inc.; Quest Diagnostics Incorporated; Eurofins Scientific SE; QuidelOrtho Corporation; Teladoc Health Inc.; Exact Sciences Corporation; Unilabs AB; LifeLabs LP; ARUP Laboratories; BioReference Health LLC; Guardant Health Inc.; DDRC Agilus Diagnostics Limited; Clinical Reference Laboratory Inc.; Freenome Holdings Inc.; Genova Diagnostics Inc.; Cerba Healthcare SAS; DELFI Diagnostics Inc.; Truvian Sciences Inc.; ACM Medical Laboratory Inc.; LabPlus; BlueHive Health.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Medical Health Screening Market Characteristics

3. Medical Health Screening Market Trends And Strategies

4. Medical Health Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Medical Health Screening Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Medical Health Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Medical Health Screening Market Growth Rate Analysis
  • 5.4. Global Medical Health Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Medical Health Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Medical Health Screening Total Addressable Market (TAM)

6. Medical Health Screening Market Segmentation

  • 6.1. Global Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Routine Tests
  • Non-Routine Tests
  • Cancer Screening Tests
  • Specialty Tests
  • Other Test Types
  • 6.2. Global Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood
  • Urine
  • Saliva
  • Other Sample Types
  • 6.3. Global Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals Or Clinics Diagnostic Laboratories
  • Workplaces
  • Research Institutes
  • Other End Users
  • 6.4. Global Medical Health Screening Market, Sub-Segmentation Of Routine Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Pressure Monitoring
  • Blood Glucose Testing
  • Lipid Profile
  • Complete Blood Count (CBC)
  • Urinalysis
  • 6.5. Global Medical Health Screening Market, Sub-Segmentation Of Non-Routine Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genetic Testing
  • Hormonal Testing
  • Allergy Testing
  • Infectious Disease Testing
  • 6.6. Global Medical Health Screening Market, Sub-Segmentation Of Cancer Screening Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mammography
  • Pap Smear Test
  • Colonoscopy
  • Prostate-Specific Antigen (PSA) Test
  • Low-Dose CT Scan For Lung Cancer
  • 6.7. Global Medical Health Screening Market, Sub-Segmentation Of Specialty Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiovascular Screening
  • Neurological Screening
  • Pulmonary Function Tests
  • Bone Density Test
  • 6.8. Global Medical Health Screening Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wellness Tests
  • Executive Health Checkups
  • Prenatal Screening
  • Occupational Health Screening

7. Medical Health Screening Market Regional And Country Analysis

  • 7.1. Global Medical Health Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Medical Health Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Medical Health Screening Market

  • 8.1. Asia-Pacific Medical Health Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Medical Health Screening Market

  • 9.1. China Medical Health Screening Market Overview
  • 9.2. China Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Medical Health Screening Market

  • 10.1. India Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Medical Health Screening Market

  • 11.1. Japan Medical Health Screening Market Overview
  • 11.2. Japan Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Medical Health Screening Market

  • 12.1. Australia Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Medical Health Screening Market

  • 13.1. Indonesia Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Medical Health Screening Market

  • 14.1. South Korea Medical Health Screening Market Overview
  • 14.2. South Korea Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Medical Health Screening Market

  • 15.1. Western Europe Medical Health Screening Market Overview
  • 15.2. Western Europe Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Medical Health Screening Market

  • 16.1. UK Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Medical Health Screening Market

  • 17.1. Germany Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Medical Health Screening Market

  • 18.1. France Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Medical Health Screening Market

  • 19.1. Italy Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Medical Health Screening Market

  • 20.1. Spain Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Medical Health Screening Market

  • 21.1. Eastern Europe Medical Health Screening Market Overview
  • 21.2. Eastern Europe Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Medical Health Screening Market

  • 22.1. Russia Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Medical Health Screening Market

  • 23.1. North America Medical Health Screening Market Overview
  • 23.2. North America Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Medical Health Screening Market

  • 24.1. USA Medical Health Screening Market Overview
  • 24.2. USA Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Medical Health Screening Market

  • 25.1. Canada Medical Health Screening Market Overview
  • 25.2. Canada Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Medical Health Screening Market

  • 26.1. South America Medical Health Screening Market Overview
  • 26.2. South America Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Medical Health Screening Market

  • 27.1. Brazil Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Medical Health Screening Market

  • 28.1. Middle East Medical Health Screening Market Overview
  • 28.2. Middle East Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Medical Health Screening Market

  • 29.1. Africa Medical Health Screening Market Overview
  • 29.2. Africa Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Medical Health Screening Market Competitive Landscape And Company Profiles

  • 30.1. Medical Health Screening Market Competitive Landscape
  • 30.2. Medical Health Screening Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Labcorp Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

31. Medical Health Screening Market Other Major And Innovative Companies

  • 31.1. QuidelOrtho Corporation
  • 31.2. Teladoc Health Inc.
  • 31.3. Exact Sciences Corporation
  • 31.4. Unilabs AB
  • 31.5. LifeLabs LP
  • 31.6. ARUP Laboratories
  • 31.7. BioReference Health LLC
  • 31.8. Guardant Health Inc.
  • 31.9. DDRC Agilus Diagnostics Limited
  • 31.10. Clinical Reference Laboratory Inc.
  • 31.11. Freenome Holdings Inc.
  • 31.12. Genova Diagnostics Inc.
  • 31.13. Cerba Healthcare SAS
  • 31.14. DELFI Diagnostics Inc.
  • 31.15. Truvian Sciences Inc.

32. Global Medical Health Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Health Screening Market

34. Recent Developments In The Medical Health Screening Market

35. Medical Health Screening Market High Potential Countries, Segments and Strategies

  • 35.1 Medical Health Screening Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Medical Health Screening Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Medical Health Screening Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제